One of the mechanisms by which these drugs work is by slowing the digestion of food by slowing gut motility as well as, in the case of the GLP-1/GIP co-agonists, reducing stomach acid
GLP-1s can accelerate weight loss via central appetite pathways and delayed gastric emptying, which amplifies that risk window
Pouwels S, Sakran N, Graham Y, Leal A, Pintar T, Yang W, Kassir R, Singhal R, Mahawar K, Ramnarain D
Use aseptic techniques to add the required volume of reconstitution buffer (PBS) to the vial, to obtain the recommended stock concentration of 250 g/mL
The Novo letter similarly challenged the omission of the MEN 2 risk but also pointed to a segment in which a patient describes stopping GLP-1 treatment after extreme nausea and vomiting blood